
Company Info
Phone(651) 587-5440
Year Established
2021
Contacts
Cathy Skinner, MACo-Founder & CEO
Rosanne Welcher, PhD, MBA, RAC
Co-Founder & COO
Kelly Christian, MS
R&D & Engineering
Company Description
NXgenPort has designed a next generation implantable chemo port-catheter utilizing microelectronic sensors that enable the remote management of patients by monitoring and reporting physiological body functions over the course of cancer treatment.